Novo Holdings Edgewise Therapeutics, Inc. Transaction History
Novo Holdings
- $1.23 Billion
- Q4 2024
A detailed history of Novo Holdings transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Novo Holdings holds 5,000,000 shares of EWTX stock, worth $135 Million. This represents 10.85% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,549,900
9.91%
Holding current value
$135 Million
Previous $148 Million
9.87%
% of portfolio
10.85%
Previous 10.36%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$407 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$241 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$167 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$163 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.98MShares$135 Million0.07% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.71B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...